NO316997B1 - Antifungalt preparat med forokt biologisk tilgjengelighet - Google Patents

Antifungalt preparat med forokt biologisk tilgjengelighet Download PDF

Info

Publication number
NO316997B1
NO316997B1 NO19985447A NO985447A NO316997B1 NO 316997 B1 NO316997 B1 NO 316997B1 NO 19985447 A NO19985447 A NO 19985447A NO 985447 A NO985447 A NO 985447A NO 316997 B1 NO316997 B1 NO 316997B1
Authority
NO
Norway
Prior art keywords
pharmaceutical preparation
preparation according
weight
preparation
ionic surfactant
Prior art date
Application number
NO19985447A
Other languages
English (en)
Norwegian (no)
Other versions
NO985447D0 (no
NO985447L (no
Inventor
Surendra A Sangekar
Winston A Vadino
Ping I Lee
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO985447D0 publication Critical patent/NO985447D0/no
Publication of NO985447L publication Critical patent/NO985447L/no
Publication of NO316997B1 publication Critical patent/NO316997B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO19985447A 1996-05-24 1998-11-23 Antifungalt preparat med forokt biologisk tilgjengelighet NO316997B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65532996A 1996-05-24 1996-05-24
PCT/US1997/019388 WO1998007429A2 (en) 1996-05-24 1997-05-21 Antifungal composition with enhanced bioavailability

Publications (3)

Publication Number Publication Date
NO985447D0 NO985447D0 (no) 1998-11-23
NO985447L NO985447L (no) 1998-11-23
NO316997B1 true NO316997B1 (no) 2004-07-19

Family

ID=24628452

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19985447A NO316997B1 (no) 1996-05-24 1998-11-23 Antifungalt preparat med forokt biologisk tilgjengelighet

Country Status (28)

Country Link
EP (1) EP0914127B1 (tr)
JP (1) JP3366648B2 (tr)
KR (1) KR100307427B1 (tr)
CN (1) CN1121860C (tr)
AR (1) AR007250A1 (tr)
AT (1) ATE213632T1 (tr)
AU (1) AU719109B2 (tr)
BR (1) BR9711167A (tr)
CA (1) CA2255663C (tr)
CO (1) CO4840511A1 (tr)
CZ (1) CZ293586B6 (tr)
DE (1) DE69710729T2 (tr)
ES (1) ES2169440T3 (tr)
HK (1) HK1017855A1 (tr)
HU (1) HU221371B1 (tr)
ID (1) ID16956A (tr)
IL (1) IL126979A (tr)
MY (1) MY118988A (tr)
NO (1) NO316997B1 (tr)
NZ (1) NZ332699A (tr)
PE (1) PE68898A1 (tr)
PL (1) PL188401B1 (tr)
RU (1) RU2207119C2 (tr)
SK (1) SK281818B6 (tr)
TR (1) TR199802424T2 (tr)
TW (1) TW504390B (tr)
WO (1) WO1998007429A2 (tr)
ZA (1) ZA974428B (tr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2157731B1 (es) * 1998-07-21 2002-05-01 Liconsa Liberacion Controlada Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
EP1175205B1 (en) 1999-11-12 2006-06-14 Abbott Laboratories Solid dispersion comprising ritonavir, fenofibrate or griseofulvin
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
DK1413331T3 (da) * 2001-01-26 2007-12-10 Schering Corp Kombinationer af peroxisomproliferatoraktiveret receptor (PPAR)-aktivatoren fenofibrat og sterolabsorptionsinhibitoren ezetimib til vaskulære indikationer
WO2004066981A1 (en) * 2003-01-29 2004-08-12 Sun Pharmaceutical Industries Limited Oral controlled release pharmaceutical composition containing metaxalone as active agent
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
SG190117A1 (en) 2010-11-01 2013-06-28 Rib X Pharmaceuticals Inc Pharmaceutical compositions
RU2450807C1 (ru) * 2011-05-11 2012-05-20 Общество с ограниченной ответственностью фирма "Вита" Стабилизированный фармацевтический состав с противогрибковым действием
CN103845292A (zh) * 2012-11-29 2014-06-11 正大天晴药业集团股份有限公司 泊沙康唑微丸及其制备方法
US9763934B2 (en) * 2014-03-05 2017-09-19 Professional Compounding Centers Of America Synergistic effect of poloxamer-based composition and itraconazole on fungus and yeast
TR201620462A2 (tr) 2016-12-31 2018-07-23 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791111A (en) * 1985-12-23 1988-12-13 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties
US5039676A (en) * 1990-05-11 1991-08-13 Schering Corporation Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof
CZ294823B6 (cs) * 1993-12-21 2005-03-16 Schering Corporation Fungicidní tetrahydrofurany

Also Published As

Publication number Publication date
PE68898A1 (es) 1998-11-10
ES2169440T3 (es) 2002-07-01
CZ293586B6 (cs) 2004-06-16
MY118988A (en) 2005-02-28
BR9711167A (pt) 1999-08-17
TR199802424T2 (tr) 1999-03-22
DE69710729T2 (de) 2002-08-14
IL126979A0 (en) 1999-09-22
KR20000065222A (ko) 2000-11-06
HU221371B1 (en) 2002-09-28
SK281818B6 (sk) 2001-08-06
AR007250A1 (es) 1999-10-27
HUP9904265A3 (en) 2000-05-29
HK1017855A1 (en) 1999-12-03
PL330480A1 (en) 1999-05-24
CA2255663A1 (en) 1998-02-26
AU719109B2 (en) 2000-05-04
WO1998007429A3 (en) 1998-04-23
NZ332699A (en) 2000-01-28
JP3366648B2 (ja) 2003-01-14
CN1121860C (zh) 2003-09-24
ID16956A (id) 1997-11-27
CA2255663C (en) 2002-08-20
AU5939998A (en) 1998-03-06
CO4840511A1 (es) 1999-09-27
TW504390B (en) 2002-10-01
ZA974428B (en) 1997-11-24
RU2207119C2 (ru) 2003-06-27
NO985447D0 (no) 1998-11-23
ATE213632T1 (de) 2002-03-15
IL126979A (en) 2000-10-31
NO985447L (no) 1998-11-23
CZ379098A3 (cs) 1999-03-17
JP2000509720A (ja) 2000-08-02
WO1998007429A2 (en) 1998-02-26
SK160898A3 (en) 1999-05-07
DE69710729D1 (de) 2002-04-04
CN1228699A (zh) 1999-09-15
HUP9904265A2 (hu) 2000-04-28
EP0914127A2 (en) 1999-05-12
KR100307427B1 (ko) 2001-12-28
EP0914127B1 (en) 2002-02-27
PL188401B1 (pl) 2005-01-31

Similar Documents

Publication Publication Date Title
US5834472A (en) Antifungal composition with enhanced bioavailability
US5846971A (en) Oral antifungal composition
DK1007030T6 (da) Fast farmaceutisk præparat indeholdende benzofuranderivater
CN104971045A (zh) 泊沙康唑药物组合物及其制备方法和药物制剂
AU731704B2 (en) Oral composition comprising a triazole antifungal compound
EP1847257B1 (en) Solid preparation comprising enteric solid dispersion
CA1172567A (en) Bendroflumethiazide formulations and method
NO316997B1 (no) Antifungalt preparat med forokt biologisk tilgjengelighet
CA2614468A1 (en) Novel granulation process and granulate produced therefrom
EA018638B1 (ru) Композиция кветиапина
CA2924706C (en) Mesoporous dosage forms for poorly soluble drugs
US20030225124A1 (en) Stable formulations of ACE inhibitors, and methods for preparation thereof
CA2368625C (en) Solubilizing aids in powder form for solid pharmaceutical presentation forms
US20070014853A1 (en) Pharmaceutical dosage form containing novel pharmaceutical granulate
WO2023111187A1 (en) Pharmaceutical compositions comprising eltrombopag
EP2946771B1 (en) Water-dispersible tablet formulation comprising deferasirox
EP3095443A1 (en) Pharmaceutical composition comprising deferasirox
MXPA98009611A (en) Antifungal composition with enhanced bioavailability

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: MERCK SHARP AND DOHME CORP

Free format text: NEW ADDRESS: 126 EAST LINCOLN AVENUE, US-NJ07065 RAHWAY, US

MM1K Lapsed by not paying the annual fees